Further, similar to the molecular glue concept already established for cereblon immunomodulatory agents [94], one can plausibly hypothesize molecular glue-like activity where a ligand-activated AhR:E3 ligase complex in the gut can degrade currently unknown and undruggable targets implicated in IBD. The gene discussed is AHR; the disease is inflammatory bowel disease.